Capital Performance Advisors LLP Novartis Ag Transaction History
Capital Performance Advisors LLP
- $597 Million
- Q3 2025
A detailed history of Capital Performance Advisors LLP transactions in Novartis Ag stock. As of the latest transaction made, Capital Performance Advisors LLP holds 1,645 shares of NVS stock, worth $216,054. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,645Holding current value
$216,054% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,572Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$993 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$935 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...